跳至主要内容
临床试验/NCT00976053
NCT00976053已完成4 期

Clinical Effectiveness of Pharmacologic Stress Radionuclide Myocardial Perfusion Imaging as a Guide to Management of Patients With Known CAD: Comparison of Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET)

Aspire Foundation2 个研究点 分布在 1 个国家目标入组 330 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
330
试验地点
2
主要终点
Diagnostic failure of SPECT vs PET

研究概览

简要总结

The purpose of this study is to compare pharmacologic stress myocardial perfusion PET with pharmacologic stress myocardial perfusion SPECT in a near-simultaneous, head-to-head comparison in the same patient. The investigators hypothesize that pharmacologic stress myocardial perfusion PET will prove superior to pharmacologic stress myocardial perfusion SPECT as a first-line diagnostic test for higher-risk patients with known coronary artery disease (CAD) who present with symptoms consistent with possible worsening of their CAD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
30 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of coronary artery disease
  • New or worsening symptoms
  • Out-patients and in-hospital patients

排除标准

  • Creatinine above 2.5 mg%
  • PCI within prior 6 months
  • Pregnant females
  • Cardiomyopathy (LVEF below 40%)
  • Significant valvular heart disease
  • Body mass index greater than 38

结局指标

主要结局

Diagnostic failure of SPECT vs PET

时间窗: 60 days

次要结局

  • Each of individual components of clinical failure(12 months)
  • Relative direct and downstream costs(3 months, 6 months, 12 months)
  • Composite of diagnostic or clinical failure(12 months)
  • Relative effect on quality of life(3 months, 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Timothy M. Bateman

Prinicpal Investigator/Medical Director

Aspire Foundation

研究点 (2)

Loading locations...

相似试验